| 7 | Proteins (Proteins, Gene)FDA Link
05/2024
-
01/2021 |
| 3 | Messenger RNA (mRNA)IBA
01/2021
-
11/2008 |
| 2 | Bleomycin (Blenoxane)FDA LinkGeneric
05/2024
-
11/2023 |
| 2 | InterferonsIBA
03/2024
-
12/2022 |
| 2 | AntigensIBA
01/2023
-
01/2009 |
| 2 | FAPI-46IBA
01/2023
-
10/2022 |
| 2 | Biomarkers (Surrogate Marker)IBA
12/2022
-
01/2021 |
| 2 | Small Interfering RNA (siRNA)IBA
10/2022
-
09/2017 |
| 2 | Naloxone (Narcan)FDA LinkGeneric
09/2010
-
10/2008 |
| 2 | Epinephrine (Adrenaline)FDA LinkGeneric
09/2010
-
10/2008 |
| 1 | Proto-Oncogene Proteins c-retIBA
05/2024 |
| 1 | selpercatinibIBA
05/2024 |
| 1 | Biotin (Vitamin H)FDA Link
05/2024 |
| 1 | biotin receptorIBA
05/2024 |
| 1 | EDDA (NiEDDA)IBA
05/2024 |
| 1 | RNA (Ribonucleic Acid)IBA
03/2024 |
| 1 | Immunosuppressive Agents (Immunosuppressants)IBA
03/2024 |
| 1 | Interferon Type IIBA
03/2024 |
| 1 | Hydroxyproline (4 Hydroxyproline)IBA
11/2023 |
| 1 | pirfenidoneIBA
11/2023 |
| 1 | ImrecoxibIBA
11/2023 |
| 1 | Antigen-Antibody Complex (Immune Complex)IBA
08/2023 |
| 1 | Interleukin-6 (Interleukin 6)IBA
08/2023 |
| 1 | zanubrutinibIBA
08/2023 |
| 1 | Agammaglobulinaemia Tyrosine KinaseIBA
08/2023 |
| 1 | Isoproterenol (Isoprenaline)FDA LinkGeneric
08/2023 |
| 1 | Adrenergic Receptors (Adrenergic Receptor)IBA
08/2023 |
| 1 | Melanins (Melanin)IBA
01/2023 |
| 1 | Evans Blue (Blue, Evans)FDA Link
01/2023 |
| 1 | RadiopharmaceuticalsIBA
01/2023 |
| 1 | AlbuminsIBA
01/2023 |
| 1 | benzamideIBA
01/2023 |
| 1 | pyridineIBA
01/2023 |
| 1 | Histone Deacetylases (Histone Deacetylase)IBA
12/2022 |
| 1 | Erlotinib Hydrochloride (CP 358,774)FDA Link
12/2022 |
| 1 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
12/2022 |
| 1 | DABIIBA
12/2022 |
| 1 | Radioisotopes (Radionuclides)IBA
10/2022 |
| 1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
10/2022 |
| 1 | Small Leucine-Rich ProteoglycansIBA
10/2022 |
| 1 | Estradiol (Delestrogen)FDA LinkGeneric
02/2022 |
| 1 | Estrogen ReceptorsIBA
02/2022 |
| 1 | 68Ga-FAPIIBA
01/2022 |
| 1 | IodineIBA
01/2022 |
| 1 | Immune Checkpoint InhibitorsIBA
01/2021 |
| 1 | DecorinIBA
01/2021 |
| 1 | AutoantibodiesIBA
11/2020 |
| 1 | osimertinibIBA
01/2020 |
| 1 | icotinibIBA
01/2020 |
| 1 | DNA (Deoxyribonucleic Acid)IBA
01/2020 |
| 1 | Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2018 |
| 1 | SurvivinIBA
11/2018 |
| 1 | Cisplatin (Platino)FDA LinkGeneric
04/2018 |
| 1 | rab GTP-Binding ProteinsIBA
04/2018 |
| 1 | Therapeutic UsesIBA
09/2017 |
| 1 | AntioxidantsIBA
03/2015 |
| 1 | tempolIBA
03/2015 |
| 1 | Phosphopyruvate Hydratase (Enolase)IBA
03/2015 |
| 1 | 2,2,6,6-tetramethylpiperidideIBA
03/2015 |
| 1 | Nitrogen OxidesIBA
03/2015 |
| 1 | Volatile Oils (Essential Oils)IBA
02/2015 |
| 1 | SesquiterpenesIBA
02/2015 |
| 1 | curdioneIBA
02/2015 |
| 1 | Drug CombinationsIBA
09/2010 |